MRNS
Marinus Pharmaceuticals Inc
Price:  
0.29 
USD
Volume:  
706,347.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS WACC - Weighted Average Cost of Capital

The WACC of Marinus Pharmaceuticals Inc (MRNS) is 5.7%.

The Cost of Equity of Marinus Pharmaceuticals Inc (MRNS) is 8.20%.
The Cost of Debt of Marinus Pharmaceuticals Inc (MRNS) is 7.00%.

Range Selected
Cost of equity 6.30% - 10.10% 8.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.4% - 6.0% 5.7%
WACC

MRNS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.53 0.94
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 10.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 4.59 4.59
Cost of debt 7.00% 7.00%
After-tax WACC 5.4% 6.0%
Selected WACC 5.7%